Publications

 
 
 
 
 

Showing 1006-1020 from 1626 publications.

  • Gabriel R, Alonso M, Brotons C, Segura A, Muñiz J. Patrón de agregación y análisis factorial de los factores de riesgo cardiovascular integrantes del síndrome metabólico en población española no diabética: estudio VIVA Av Diabetol 2009; 25(2): 131-138

    IF: 0

    View abstract

  • Modrego J, Moñux G, Mateos-Cáceres PJ, Martínez-López I, Segura A, Zamorano-León JJ, Sierra PR, Rodríguez-Sierra P, Serrano J, Macaya C, López-Farré AJ. Effects of platelets on the protein expression in aortic segments: A proteomic approach. J. Cell. Biochem. 2010 Nov; 111(4): 889-98

    IF: 2.935, Quartile: 2

    View abstract

  • Bodí V, Sanchis J, Núñez J, Lopez-Lereu MP, Mainar L, Bosch MJ, Dominguez E, Husser O, Chorro FJ, Llàcer A. [Abnormal myocardial perfusion after infarction in patients with persistent TIMI grade-3 flow. Only an acute phenomenon?]. Rev Esp Cardiol 2007 May; 60(5): 486-92

    IF: 2.88, Quartile: 2

    View abstract

  • Núñez J, Sanchis J, Núñez E, Bodí V, Bertomeu-González V, Bosch MJ, Santas E, Fácila L, Chorro FJ, Gómez C, Consuegra L, Llàcer A. Prognostic differences between routine invasive and conservative strategies for the management of high-risk, non-ST segment acute coronary syndromes: Experience from two consecutive periods in a single center. Eur. J. Intern. Med. 2007 Sep; 18(5): 409-16

    IF: 0

    View abstract

  • Chorro FJ, Blasco E, Trapero I, Cánoves J, Ferrero A, Mainar L, Such-Miquel L, Sanchis J, Bodí V, Cerdá JM, Alberola A, Such L. Selective myocardial isolation and ventricular fibrillation. Pacing Clin Electrophysiol 2007 Mar; 30(3): 359-70

    IF: 1.561, Quartile: 3

    View abstract

  • Núñez J, Núñez E, Consuegra L, Sanchis J, Bodí V, Martínez-Brotons A, Bertomeu-González V, Robles R, Bosch MJ, Fácila L, Darmofal H, Llàcer A. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Heart 2007 Jun; 93(6): 716-21

    IF: 0, Quartile: 1

    View abstract

  • Bodí V, Sanchis J, Lopez-Lereu MP, Nunez J, Mainar L, Pellicer M, Sanz R, Gómez C, Bosch MJ, Husser O, Chorro FJ, Llàcer A. Evolution of 5 cardiovascular magnetic resonance-derived viability indexes after reperfused myocardial infarction. Am. Heart J. 2007 Apr; 153(4): 649-55

    IF: 3.649, Quartile: 1

    View abstract

  • Carbonell N, Blasco M, Sanjuán R, Pérez-Sancho E, Sanchis J, Insa L, Bodí V, Núñez J, García-Ramón R, Miguel A. Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial. Int. J. Cardiol. 2007 Jan; 115(1): 57-62

    IF: 0, Quartile: 2

    View abstract

  • Galisteo M, Morón R, Rivera L, Romero R, Anguera A, Zarzuelo A. Plantago ovata husks-supplemented diet ameliorates metabolic alterations in obese Zucker rats through activation of AMP-activated protein kinase. Comparative study with other dietary fibers. Clin Nutr 2010 Apr; 29(2): 261-7

    IF: 3.274, Quartile: 1

    View abstract

  • Moreno JM, Rodriguez Gomez I, Wangensteen R, Perez-Abud R, Duarte J, Osuna A, Vargas F. Mechanisms of hydrogen peroxide-induced vasoconstriction in the isolated perfused rat kidney. J. Physiol. Pharmacol. 2010 Jun; 61(3): 325-32

    IF: 1.489, Quartile: 3

    View abstract

  • Romero M, Jimenez R, Sánchez M, López-Sepúlveda R, Zarzuelo A, Tamargo J, Perez-Vizcaino F, Duarte J. Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation. Atherosclerosis 2010 Sep; 212(1): 78-85

    IF: 4.522, Quartile: 1

    View abstract

  • Caballero R, Dolz-Gaitón P, Gómez R, Amorós I, Barana A, González de la Fuente M, Osuna L, Duarte J, López-Izquierdo A, Moraleda I, Gálvez E, Sánchez-Chapula JA, Tamargo J, Delpón E. Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification. Proc. Natl. Acad. Sci. U.S.A. 2010 Aug; 107(35): 15631-6

    IF: 0, Quartile: 1, Decile: 1

    View abstract

  • Tamargo J, Duarte J, Caballero R, Delpón E. Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure. Curr Opin Investig Drugs 2010 Sep; 11(9): 1039-47

    IF: 3.549, Quartile: 1

    View abstract

  • Cantero-Recasens G, Gonzalez JR, Fandos C, Duran-Tauleria E, Smit LA, Kauffmann F, Antó JM, Valverde MA. Loss of function of transient receptor potential vanilloid 1 (TRPV1) genetic variant is associated with lower risk of active childhood asthma. J. Biol. Chem. 2010 Sep; 285(36): 27532-5

    IF: 5.328, Quartile: 1

    View abstract

  • Bosch X, Marrugat J, Sanchis J. Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes. Cochrane Database Syst Rev 2010; (9): CD002130

    IF: 5.653, Quartile: 1, Decile: 1

    View abstract

An initiative of

Ministerio de Economía y Competitividad Fondo Europeo de Desarrollo Regional IMIM - Parc de Salut Mar